-
Calls to Expand THN Program…
Great piece in Pharmacy Daily today with comments from HRA Board member, Dr Chris Alderman to support the launch of our new Take-Home Naloxone Policy Brief. Read the piece here… https://www.pharmacydaily.com.au/news/calls-to-expand-thn-program/118673 […]
-
Take-Home Naloxone Policy Brief
Take-Home, Take Action: Improving Naloxone Uptake in Australia. Naloxone is a safe and effective drug that temporarily reverses the effects of an opioid overdose. While a National Take-Home Naloxone (THN) Program has been established, the distribution of THN remains suboptimal across Australia. HRA’s new Take-Home Naloxone Policy Brief outlines the current state of play and makes the case for expanding access…
-
Safe Injecting Rooms Save Lives…
Why are Councils turning their backs on them? Read our opinion piece by Greg Denham, HRA Board member published by Sydney Criminal Lawyers to support the launch of our new Drug Consumption Rooms Policy Brief today. Read here… https://www.sydneycriminallawyers.com.au/blog/supervised-injecting-rooms-save-lives-why-are-councils-turning-their-backs-on-them/ […]
-
Drug Consumption Rooms Policy Brief
Despite the evidence supporting drug consumption rooms (DCRs) as effective public health interventions, currently only two such facilities are permitted by government to operate nationally – leaving many high-need communities underserved. HRA’s new Drug Consumption Rooms Policy Brief outlines the current state of play and makes the case for expanding access to DCRs in Australia. […]
-
From Red Tape to Person-Centred Care
Reforming Australia’s Opioid Treatment Program Read our opinion piece published in Bio Pharma Dispatch to support the launch of our new Opioid Treatment Program Policy Brief today. Read here…https://pharmadispatch.com/news/reforming-australias-opioid-dependence-treatment-program-from-red-tape-to-person-centred-care […]
-
Opioid Treatment Program Policy Brief
Reforming Australia’s Opioid Treatment Program Investing in Access, Equity & Sustainability Australia’s Opioid Treatment Program (OTP) is a critical, evidence-based response to opioid dependence, that provides access to life-saving pharmacotherapy medications. HRA’s new Opioid Treatment Program Policy Brief outlines some of the key challenges facing the OTP in Australia and provides a series of evidence-based recommendations for creating a more responsive,…
-
Tobacco Harm Reduction Policy Brief
Adverse Effects of High Cigarette Taxation and the De Facto Prohibition of Vapes See HRA’s new Tobacco Harm Reduction Policy Brief to understand why Australia should urgently reform its current tobacco control strategy to an evidenced-based harm reduction approach including reducing tobacco excise, establishing a legal, regulated market for lower risk nicotine products and, shifting investment from enforcement to regulation……
